THE EFFECTIVENESS OF RENALOF® COMPARED TO KALKURENAL® AND PLACEBO
##plugins.themes.bootstrap3.article.main##
##plugins.themes.bootstrap3.article.sidebar##
Abstract
Objective: To compare the effectiveness after administration of Renalof to Kalkurenal and placebo in patient with renal calculus. Material & Method: We analyzed 30 patient with renal calculi less than or equal to 20 mm (2 cm) between January 2011 and March 2011. Patients were divided into 3 groups. Nine patients were treated with placebo, 8 patients were treated with Kalkurenal and the last 13 patients were treated with Renalof. After 30 days, we analyzed calcium and uric acid excretion for 24 hours and measured the stone with plain abdominal film and renal ultrasound. Results: There were decreased in excretion of calcium and uric acid all of patients but not significant statistically (p > 0,05) and there were significant decreased on stone measurement in patient treated with Renalof. Conclusion: Renalof can be given as adjunct therapy for patient with renal calculi. Keywords: Calcium and uric acid excretion in urine 24 hours, stone measurement and stone surface area.
##plugins.themes.bootstrap3.article.details##
Stoller ML, Bolton DM. Urinary stone disease etiology, diagnosis and management. In: Tanagho EA and McAninch JW. 14th ed. Smith’s General Urology. 1995; 276-300.
Menon M, Resnick MI. Urinary lithiasis: Etiology, diagnosis and medical management. In: Campbell MF, Walsh PC, Retik AB, Vaughan ED, Wein AJ. 8th ed. WB Saunders. Campbell’s Urology. 1998; 3: 2662-94.
Rochani S. Guideline penatalaksanaan penyakit batu saluran kemih. 2007. p. 1-45.
Soebadi, DM. Laporan Tahunan 2005. Surabaya: Bagian Urologi RSU Dr. Soetomo - FK Unair; 2006.
Wolf JS. Nephrolithiasis. http://emedicine.medscape.com.2010
Lotan Y. Economic and cost of care of stone disease. Journal of the National Kidney Foundation. 2009; 16(1): 5.
Worcester EM, Coe FL. Cinical practice: Calcium kidney stone. N Engl J Med. 2010; 363: 954-63.
Munver R, Preminger JM. Urinary tract stone. In: Weiss RM, George NJR, O’Reilly PH. Comprehensive Urology. London: Mosby International Limited; 2001. p. 313-23.
Craig S. Renal calcul. 2010. www.emedicine.medscape.com
Pietrow PK, Karellas ME. Medical management of common urinary calculi. America Family Physician. 2006; 74(1): 86-94.
Wibisono. Karakteristik pasien batu ginjal di RSU Dr. Soetomo Januari 2007-Desember 2009. Surabaya: Bagian Urologi RSU Dr Soetomo-FK Unair; 2010.
Miller NL. Management of kidney stone. BMJ. 2007. p. 334.
Osman MM, Alfano Y, Kamp S, Haecker A, Alken P, Michel MS, et al. 5 years follow up of patients with clinically insignificant residual fragment after extracorporeal shockwave lithotripsy. European Urology. 2005; 47: 860-4.
Tan YH, Wong M. How significant are clinically insignificant residual fragments following lithotripsy? Curr Opin Urol. 2005; 15: 127-31.
Tracy CR, Pearle MS. Update on the medical management of stone disease. Current Opinion in Urology. 2009; 9(2): 200-4.